Compound

Haloperidol

ATC Index

Haloperidol: Antipsychotic Medication for Severe Mental Illness

Learn about Haloperidol, a potent antipsychotic medication (ATC N05) used to manage severe psychotic disorders, Tourette's syndrome, and acute agitation. Understand its mechanism, uses, and important safety information.

Haloperidol buy Haloperidol Haloperidol dosage Haloperidol side effects Haloperidol for sale pharmaceutical medical drug information
ATC Code: N05
Last updated: Feb 25, 2026
Medical Reference

Looking to order Haloperidol?

Browse our catalog for available pharmaceutical products and competitive pricing.

View Products

What is Haloperidol?

Haloperidol is a potent antipsychotic medication belonging to the butyrophenone class. It is classified as a first-generation, or typical, antipsychotic. Primarily used in the management of severe mental and behavioral disorders, Haloperidol helps to alleviate symptoms such as hallucinations, delusions, and disorganized thought processes by affecting certain chemical messengers in the brain. Its efficacy in controlling acute psychotic episodes and chronic conditions has made it a cornerstone in psychiatric treatment for decades.

As an antipsychotic, Haloperidol falls under the ATC code N05, which designates psycholeptics, specifically antipsychotics. It is known for its strong dopaminergic blocking activity, which is central to its therapeutic effects. Available in various formulations, including oral tablets, oral solution, and injectable forms, Haloperidol offers flexibility in administration to suit different clinical needs, from acute emergency situations to long-term maintenance therapy.

Mechanism of Action

The primary mechanism of action of Haloperidol involves the potent antagonism of dopamine D2 receptors in the brain. By blocking these receptors, particularly in the mesolimbic pathway, Haloperidol reduces excessive dopaminergic activity, which is believed to contribute to the positive symptoms of psychosis, such as hallucinations and delusions. This receptor blockade helps to stabilize mood and thought processes in affected individuals.

  • Dopamine D2 Receptor Antagonism: Haloperidol exhibits a high affinity for D2 receptors, leading to significant blockade and reduction of dopamine signaling.
  • Impact on Mesolimbic Pathway: The therapeutic effects are largely attributed to its action in the mesolimbic pathway, where it helps to normalize dopamine levels.
  • Reduction of Psychotic Symptoms: By modulating dopamine activity, Haloperidol effectively diminishes the severity of psychotic symptoms.
  • Additional Receptor Interactions: Haloperidol also possesses weak alpha-1 adrenergic and muscarinic cholinergic antagonistic properties, which may contribute to some of its side effects.

Medical Uses

Primary Uses:

  • Schizophrenia (acute and chronic management)
  • Acute psychotic episodes
  • Mania in bipolar disorder
  • Severe behavioral problems in children (e.g., aggression, hyperactivity)
  • Tourette's syndrome (for severe tics)

Secondary Uses:

  • Acute agitation (often in emergency settings)
  • Nausea and vomiting (off-label, typically for refractory cases)
  • Delirium (especially hyperactive type)

Dosage

IndicationTypical DoseFrequencyRoute
Acute Psychosis/Agitation2-5 mgEvery 4-8 hours as neededOral, Intramuscular (IM)
Chronic Schizophrenia0.5-20 mg/dayOnce or twice dailyOral
Tourette's Syndrome0.5-5 mg/dayOnce or twice dailyOral

Note: Dosages for Haloperidol are highly individualized and must be determined by a healthcare professional based on the patient's condition, response to treatment, and tolerability.

Side Effects

Common Side Effects:

  • Extrapyramidal symptoms (EPS), including dystonia, akathisia, and parkinsonism
  • Sedation or drowsiness
  • Dry mouth
  • Blurred vision
  • Constipation
  • Dizziness
  • Weight gain
  • Restlessness

Rare but Serious Side Effects:

  • Neuroleptic Malignant Syndrome (NMS): A life-threatening neurological disorder
  • Tardive Dyskinesia (TD): Involuntary, repetitive body movements, often irreversible
  • QT prolongation and other cardiac arrhythmias
  • Seizures
  • Agranulocytosis (severe reduction in white blood cells)
  • Liver dysfunction

Warnings

Haloperidol is contraindicated in patients with Parkinson's disease, severe central nervous system (CNS) depression, comatose states, or known hypersensitivity to the drug. Caution should be exercised in patients with pre-existing cardiac conditions, epilepsy, or significant liver or kidney impairment. Abrupt discontinuation of Haloperidol can lead to withdrawal symptoms or a relapse of psychotic symptoms, hence it should always be tapered under medical supervision.

This article provides general information about Haloperidol and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis, treatment, and before making any decisions related to your health or medication. Do not start, stop, or change any medication without medical supervision.

Contact us on WhatsApp

Chat with our support team instantly on WhatsApp.

WhatsApp Chat on WhatsApp